pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
300
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 3
B-244
Acne Vulgaris
AOBiome Therapeutics Inc
0
catalysts
Phase 2
BCX-17725
Netherton Syndrome (Bamboo Hair)
$BCRX
BIOCRYST PHARMACEUTICALS INC
0
catalysts
Phase 2
BLU-808
Chronic Inducible Urticaria
Blueprint Medicines Corp
0
catalysts
Preclinical
BPC-157
Inflammation
← prev
page 4 of 10
next →
131
Pain
89
Neurology
1
PharmaTher Holdings Ltd
0
catalysts
Phase 1
BREAD-01
Atopic Dermatitis (Atopic Eczema)
Brexogen Inc
0
catalysts
Phase 1
BSI-502
Atopic Dermatitis (Atopic Eczema)
$ACRS
Aclaris Therapeutics, Inc.
0
catalysts
Phase 1
CAN-10
Hidradenitis Suppurativa
Otsuka Pharmaceutical Co Ltd
0
catalysts
Phase 2
CBL-514
Adiposis Dolorosa (Dercum's Disease or Anders Disease)
Caliway Biopharmaceutics Co Ltd
0
catalysts
Preclinical
CD6/CTLA4 CAR-Treg-Dermatological Basket
Psoriasis
Immuthera Inc
0
catalysts
Phase 1
CORDStrom
Dystrophic Epidermolysis Bullosa
$INMB
Inmune Bio, Inc.
0
catalysts
Phase 2
CX-001
Nevus
Calissa Therapeutics
0
catalysts
Phase 1
Corlicyte
Diabetic Foot Ulcers
Cellresearch Corp Pte Ltd
0
catalysts
Phase 2
DLQ-01
Androgenic Alopecia
Dermaliq Therapeutics Inc
0
catalysts
Marketed
Desowen
Desonide Actavis (desonide)
Psoriasis
Teva Pharmaceuticals USA Inc
0
catalysts
Phase 1
Drug for Unspecified Dermatological Disorders
Unspecified Dermatological Disorders
Neutrophil collagenase
Interstitial collagenase
TBT Pharma Inc
0
catalysts
Phase 2
ELU-42
Diabetic Foot Ulcers
Eluciderm Inc
0
catalysts
Phase 3
ENERGIF-703
Diabetic Foot Ulcers
Energenesis Biomedical Co Ltd
0
catalysts
Phase 1
ENS-002
Atopic Dermatitis (Atopic Eczema)
Concerto Biosciences Inc
0
catalysts
Phase 2
EVO-756
Chronic Inducible Urticaria
$EVMN
Evommune, Inc.
0
catalysts
Preclinical
EVXB-1
Abscess
$EVAX
Evaxion A/S
0
catalysts
Phase 3
EX-03
EscharEx
Venous Leg Ulcers (Crural Ulcer)
$MDWD
MediWound Ltd.
0
catalysts
Phase 2
EXG-34217
Dyskeratosis Congenita (Zinsser-Cole-Engman Syndrome)
Elixirgen Therapeutics Inc
0
catalysts
Phase 3
Ebesanar
Dystrophic Epidermolysis Bullosa
RHEACELL GmbH & Co KG
0
catalysts
Phase 2
FB-825
Atopic Dermatitis (Atopic Eczema)
Oneness Biotech Co Ltd
0
catalysts
Preclinical
First Program
Congenital Ichthyosis
Epithelica GmbH
0
catalysts
Phase 1
GS-6791
Rheumatoid Arthritis
$GILD
GILEAD SCIENCES, INC.
0
catalysts
Phase 1
HCW-9302
Alopecia Areata
$HCWB
HCW Biologics Inc.
0
catalysts
Preclinical
Human Decorin Fused to the Truncated Homing Peptide CRK
Epidermolysis Bullosa
Theravia SAS
0
catalysts
Phase 2
IMB-101
Hidradenitis Suppurativa
Navigator Medicines Inc
0
catalysts
Phase 2
IMG-007
Atopic Dermatitis (Atopic Eczema)
$IMA
ImageneBio, Inc.
0
catalysts
